Monocyte chemotaxis in leukemia patients

References

1. • Rubin RH
   • Cosimi AB
   • Goetzl EJ
   Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma.
   Clin Immunol Immunopathol. 1976; 6: 376
   • Google Scholar
2. • McVie JG
   • Logan EC
   • Kay AB
   Monocyte function in cancer patients.
   Eur J Cancer. 1977; 13: 351
   • Google Scholar
3. • Hausman MS
   • Brosman S
   • Snyderman R
   • et al.
   Defective monocyte function in patients with genitourinary carcinoma.
   J Natl Cancer Inst. 1975; 55: 1047
   • Google Scholar
4. • Snyderman R
   • Pike MC
   Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.
   Am J Pathol. 1977; 88: 727
   • Google Scholar
5. • Boetcher DA
   • Leonard EJ
   Abnormal monocyte chemotactic response in cancer patients.
   J Natl Cancer Inst. 1974; 52: 1091
   • Google Scholar
6. • Snyderman R
   • Mergerhagen SE
   Chemotaxis of Macrophages.
   in: Nelson DS Immunobiology of the Macrophage. Academic Press, Inc, New York1976: 323
   • Google Scholar
7. • Snyderman R
   • Pike C
   An inhibitor of macrophage chemotaxis produced by neoplasms.
   Science. 1976; 192: 370
   • Google Scholar
8. • Pike MC
   • Snyderman R
   Depression of macrophage function by a factor produced by neoplasms: a mechanism for abrogation of immune surveillance.
   J Immunol. 1976; 117: 1243
   • Google Scholar
9. • Noonan SJ
   • Sorkin E
   Cell-specific defect in monocyte function during tumor growth.
   J Natl Cancer Inst. 1976; 57: 135
   • Google Scholar
10. • North RJ
    • Kirstein DP
    • Tuttle RL
    Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.
    J Exp Med. 1976; 143: 559
    • Google Scholar
11. • North RJ
    • Kirstein DP
    • Tuttle RL
    Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.
    J Exp Med. 1976; 143: 574
    • Google Scholar
12. • King GW
    • Yanes B
    • Hurtubise PE
    • et al.
    Immune function of successfully treated lymphoma patients.
    J Clin Invest. 1977; 57: 1451
    • Google Scholar
13. • King G
    • Bain G
    • LoBuglio A
    The effect of tuberculosis and neoplasia on human monocyte staphylocidal activity.
    Cell Immunol. 1975; 16: 389
    • Google Scholar
14. • Gesner BM
    • Howard JG
    Handbook of Experimental Immunology. F. A. Davis Co, Philadelphia1967: 1009
    • Google Scholar
15. • Weston WL
    • Dustin RD
    • Hecht SK
    Quantitative assays of human monocyte macrophage function.
    J Immunol Methods. 1975; 8: 213
    • Google Scholar
16. • Herbermann RB
    • Char D
    • Oldham R
    • et al.
    Cell-mediated immunity in human acute leukemia.
    Bibl Haematol. 1975; 40: 648
    • Google Scholar
17. • Hersh EM
    • Gutterman JU
    • Mavligit GM
    • et al.
    Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    J Clin Invest. 1974; 54: 401
    • Google Scholar
18. • Churchill WH
    • Rocklin RR
    • Maloney WC
    • David JR
    • et al.
    In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Natl Cancer Inst Monogr. 1973; 36: 99
    • Google Scholar
19. • Humphrey GB
    • et al.
    Lymphocyte transformation in leukemic serum.
    Cancer. 1975; 35: 1341
    • Google Scholar
20. • Bobrave AM
    • Fuks Z
    • Strober S
    • et al.
    Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Cancer. 1975; 36: 169
    • Google Scholar
21. • Gajl-Peczalska KJ
    • Bloomfield CD
    • Coccia PF
    • et al.
    B and T Cell lymphomas: analysis of blood and lymph nodes in 87 patients.
    Am J Med. 1975; 59: 674
    • Google Scholar
22. • Hibbs Jr, JB
    • Lambert Jr, LH
    • Remington JS
    Possible role of macrophage mediated nonspecific cytotoxicity in tumor resistance.
    Nature. 1972; 235: 48
    • Google Scholar
23. • Evans R
    • Alexander P
    Mechanisms of immunologically specific killing of tumor cells by macrophages.
    Nature. 1972; 236: 168
    • Google Scholar
24. • Yamamura Y
    Immunologic responses to a murine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors.
    Int J Cancer. 1977; 19: 717
    • Google Scholar
25. • Snyderman R
    • Siegler HF
    • Meadows L
    Abnormalities of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal.
    J Natl Cancer Inst. 1977; 58: 37
    • Google Scholar
26. • Norris DA
    • Perez RE
    • Golitz LE
    • Seitz LE
    • Weston WL
    Defective monocyte chemotaxis in mycosis fungoides: lack of essential helper lymphocytes.
    Cancer. 1979; 44: 124
    • Google Scholar
27. • Teshima H
    • Wanebo H
    • Pinsky C
    • et al.
    Circulating immune complexes detected by ¹³⁵I Clq deviation test in sera of cancer patients.
    J Clin Invest. 1977; 59: 1134
    • Google Scholar
28. • Norris DA
    • Huff JC
    • Thorne EG
    • Swinehart JM
    Inhibition of monocyte chemotaxis by in vitro incubation with cryoimmunoglobulins from patients with malignant melanoma.
    J Invest Dermatol. 1979; 72: 275
    • Google Scholar
29. • Carpenter NA
    • Lange GT
    • Fiere DM
    • et al.
    Clinical relevance of circulating immune complexes in human leukemia.
    J Clin Invest. 1977; 60: 874
    • Google Scholar